Table 3.
Estimated Association of Selected Perioperative Outcomes Comparing Surgical Approach (RVATS to VATS; N = 133)
| Outcomesa | Crude point estimateb | 95% CI | P | Adjusted point estimatec | 95% CI | P |
|---|---|---|---|---|---|---|
| Conversion | 0.36 | 0.14 to 0.90 | .029 | 0.18 | 0.14 to 0.90 | .007 |
| Length of hospital stay (days) | 0.95 | −0.84 to 2.73 | .296 | 0.89 | −1.03 to 2.80 | .360 |
| Perioperative eventsd | 1.88 | 0.60 to 5.93 | .284 | 1.62 | 0.47 to 5.66 | .448 |
| Reoperation | 4.74 | 0.48 to 46.84 | .183 | 3.86 | 0.34 to 43.77 | .277 |
a
VATS = reference group.
b
Point estimates reflect odds ratios, but for length of hospital stay, which reflects the difference in mean days of hospital stay for RVATS compared to VATS.
c
Adjusted for stage (I versus II–III).
d
Perioperative events include occurrence of tracheostomy, reintubation, pneumonia, pulmonary embolism, stroke, or reoperation.
CI, confidence interval; RVATS, robotic video-assisted thoracoscopic surgery; VATS, video-assisted thoracoscopic surgery.